The value of immunotherapy in head and neck cancer-Reference-Cited by-同舟云学术

The value of immunotherapy in head and neck cancer

Published:2018-12-20 Issue:1 Volume:19 Page:35-43
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Manca Paolo¹,Raez Luis E.²,Salzberg Matthew²,Sanchez Jorge³,Hunis Brian²,Rolfo Christian⁴^ORCID

Affiliation:

1. Medical Oncology Department, Campus Bio-medico University, Rome, Italy

2. Memorial Cancer Institute/Florida International University, Hollywood, FL, USA

3. Departamento de Oncologia, Hospital Edgardo Rebagliati Martins, Lima, Peru

4. Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland, USA

Funder

not funded

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2019.1556637

Reference116 articles.

1. The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications

2. J F, I S, M E, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancer base no. 11 available at international agency for research on cancer

3. 2013 cited 2017 Dec 21. Available from: http://globocan.iarc.fr

4. Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck

5. Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allergy History and Immunotherapy Response in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma;Otolaryngology–Head and Neck Surgery;2023-12-20

2. Combination therapy with immune checkpoint inhibitors in recurrent or metastatic squamous cell carcinoma of the head and neck: A meta-analysis;International Immunopharmacology;2023-06

3. Diagnostic Predictors of Immunotherapy Response in Head and Neck Squamous Cell Carcinoma;Diagnostics;2023-02-23

4. PDK1- and PDK2-mediated metabolic reprogramming contributes to the TGFβ1-promoted stem-like properties in head and neck cancer;Cancer & Metabolism;2022-12-06

5. Tumor Histological Grade and Immunotherapy Response in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma;JAMA Otolaryngology–Head & Neck Surgery;2022-06-01